Gentherm Announces Termination of Shareholder Rights Plan
Mar 05, 2018 22:05 pm UTC| Business
NORTHVILLE, Mich., March 05, 2018 -- Gentherm Incorporated (NASDAQ:THRM), the global market leader and a developer of innovative thermal management technologies, announced today that its Board of Directors unanimously...
PennantPark Investment Corporation Announces Quarterly Distribution of $0.18 per Share
Mar 05, 2018 22:05 pm UTC| Business
NEW YORK, March 05, 2018 -- PennantPark Investment Corporation (the "Company") (NASDAQ:PNNT) declares second fiscal quarter 2018 distribution of $0.18 per share, payable on April 2, 2018 to stockholders of record as of...
YY Reports Fourth Quarter and Full Year 2017 Unaudited Financial Results
Mar 05, 2018 22:00 pm UTC| Business
GUANGZHOU, China, March 06, 2018 -- YY Inc. (NASDAQ:YY) ("YY" or the "Company"), a leading live streaming social media platform in China, today announced its unaudited financial results for the fourth quarter and full...
Otelco Reports Fourth Quarter and 2017 Results
Mar 05, 2018 22:00 pm UTC| Business
ONEONTA, Ala, March 05, 2018 -- Otelco Inc. (NASDAQ:OTEL), a wireline telecommunications services provider in Alabama, Maine, Massachusetts, Missouri, New Hampshire, Vermont and West Virginia today announced results for...
Huttig Building Products, Inc. Announces Fourth Quarter and Full Year 2017 Results
Mar 05, 2018 22:00 pm UTC| Business
Fourth Quarter and Full Year 2017 Highlights: Net sales of $179.2 million and $753.2 million, respectivelyGross margin of 20.5% and 20.7%, respectively Net loss of $9.8 million and $7.1 million, respectivelyTotal...
Just Energy Group to Present at CIBC’s Annual Industrials Conference
Mar 05, 2018 22:00 pm UTC| Business
TORONTO, March 05, 2018 -- Just Energy Group Inc. (TSX:JE) (NYSE:JE), a leading retail energy provider specializing in electricity and natural gas commodities, energy efficiency solutions, and renewable energy options,...
Mar 05, 2018 22:00 pm UTC| Business
WALTHAM, Mass., March 05, 2018 -- Proteon Therapeutics, Inc. (Nasdaq:PRTO), a company developing novel, first-in-class therapeutics to address the medical needs of patients with kidney and vascular diseases, today...